• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Document
Document

... -Extensive metabolizers; or -poor metabolizers no pain relief from codeine prodrug for morphine catalyzed by CYP2D6 4-hydroxylase Other genetic variations- 1:3000 occurrence atypical cholinesterasewill not metabolize topical anasthetic succinycholine these individuals may stay “frozen” for days or w ...
Pharmacologic Principles
Pharmacologic Principles

... • Amount of drug circulating = concentration • Patient condition – liver & kidney health, age, GI function • Tolerance or Dependence • Interactions ...
PPTX - Interfaces.com
PPTX - Interfaces.com

... Auranofin targets parasite thioredoxin reductase ...
Clinical Trials
Clinical Trials

... • For serious diseases, the FDA may permit extensive but controlled marketing of a new drug before phase 3 studies are completed; • For life threatening disease, it may permit controlled marketing even before phase 2 studies have been completed; • Once approval to market the drug has been obtained, ...
Chapter 3.Litho
Chapter 3.Litho

... long-term abuse. inhaled. The effects of methadone, which is usually taken orally, may last up to 24 hours. acute illness) may not be due to an excessive quantity of the drug but to an interaction with other It can happen that opiate dependence brings few psychoactive substances or with adulterants ...
8th Grade Illegal Drugs
8th Grade Illegal Drugs

... Drug Slipping: placing a drug in someone’s food or beverage without that person’s knowledge, therefore making them vulnerable to physical or ...
Medicinal chemistry
Medicinal chemistry

... • After 1930’s: The development of new drugs was speeded greatly by the close combination of Medicinal Chemistry and Experimental Pharmacology. • Theory of antimetabolite was formed by using metabolic products as lead compounds. • Discovery of penicillin which is the first antibiotics is an epoch-m ...
39- Antituberculosis drugs
39- Antituberculosis drugs

...  Infections caused by stapylococci and other rifampicin-susceptible bacteria (4)Adverse reactions  Gastrointestinal disturbance  Liver toxicity: cholestatic jaundice, hepatitis ...
Name NOTES – FORENSIC SCIENCE DRUGS CHAPTER 9 Drug
Name NOTES – FORENSIC SCIENCE DRUGS CHAPTER 9 Drug

... Drug Control Laws a. Controlled Substance Act i. 5 Schedules of classification based on drugs potential for abuse, potential for physical and psychological dependence, and medical value ii. Penalties for possession, use, sale, etc, are related to classification schedule Drug Identification a. Diffic ...
THE DISTURBANCES OF ABSORPTION
THE DISTURBANCES OF ABSORPTION

... According to the European Medicines Evaluation Agency (EMEA): bioavailability means the rate and extent (amount) to which the active substance or active moiety is absorbed from a pharmaceutical form, and becomes available at the site of action (in the general circulation). Bioavailability is defined ...
Prescription_Drugs_Information_Fact_Sheet
Prescription_Drugs_Information_Fact_Sheet

... There are also over-the-counter drugs that are abused or misused. For example, cold and cough medicines may contain intoxicating chemicals. For example, dextromethorphan is a drug that clears mucus, but too much of it can get a person high and cause hallucinations. Pseudoephedrine is found in over-t ...
Narcotics - JustAnswer
Narcotics - JustAnswer

... They actually block certain receptors that send pain information from the point of origin through the nervous system to the brain. Because of the effect these drugs have on the users, they are highly addictive. Some examples of narcotics are: morphine, codeine and heroin. Morphine is a pain medicati ...
DRUGS IN SPORT
DRUGS IN SPORT

...  During this time injury can affect performance or the ability to train.  Some are tempted to take drugs, which can help in healing the injury quicker and therefore, the ability to train more.  Coaches can also put pressure on a sportsperson. They also receive endorsements, sponsorship or payment ...
Not my Kid Powerpoint - Chardon Local Schools
Not my Kid Powerpoint - Chardon Local Schools

... of states; if the present trend continues, prescription drug overdose will be the leading cause of death by accident. ...
Names
Names

...  Drug company selects a trade name; gets sole proprietary rights of drug for 20 years (from the time they start the process, preclinical trials and clinical trials can take up to 10 years before the drug ever makes it to market) ...
DRUGS - PBworks
DRUGS - PBworks

... What doest his matter? It’s easier to use by IV Provides high that lasts 3 – 4 hours – deep sense of well being, drowsiness ...
ISHIK UNIVERSITY FACULTY OF DENTISTRY
ISHIK UNIVERSITY FACULTY OF DENTISTRY

... Greek: Pharmacos (drug) + logos (study) The study of substances that interact with living system through chemical processes, especially by binding to regulatory molecules and activating or inhibiting normal body processes. ...
Rash
Rash

... • 21.3% > 65yr (community dwelling) at least 1 inappropriate Rx drug • 23% of nursing home admissions due to medication problems (J. Am. Pharm. Assoc.:Nov 2002) ...
Title
Title

... Brody, T M et al, Human Pharmacology: Molecular to Clinical, Mosby Gard, P R, Human Pharmacology, Taylor and Francis Foster, R W, Basic Pharmacology, Butterworth-Heinemann Neal, M J, Medical Pharmacology at a Glance, Blackwell ...
Document
Document

... requirement that a wide range of drugs be available to consumers only when prescribed by a licensed physician • The argument that the requirement of prescriptions from physicians is not in the public interest is made more plausible when one observes the many near-equivalents to newer prescription dr ...
Lecture 4 Outline – Administration, Absorption
Lecture 4 Outline – Administration, Absorption

... Absorption of Drugs – getting the drug into the bloodstream (except IV) ...
Biological therapies of schizophrenia
Biological therapies of schizophrenia

... However the appropriateness of drug treatment is debatable. While it may be a more humane approach than ECT or restraints that were used in the past and they are relatively cheap (they are free at point of delivery in the UK) and can allow schizophrenics to live a relatively normal life, it is quest ...
Discussion Continuum 1: Who pays to develop drugs? Introduction
Discussion Continuum 1: Who pays to develop drugs? Introduction

... country by the government. Governments can attempt to keep prices low either by enforcing low prices, or by loosening regulations in an attempt to encourage competition. Patents and generic drugs When a pharmaceutical company first markets a drug, it is usually under a patent that allows only the ph ...
Chapter 1 - Drugs and Agents - Factors Affecting their Action
Chapter 1 - Drugs and Agents - Factors Affecting their Action

... The metabolism of a drug and its passage from the liver into the circulation ...
What are Drugs? - Noadswood Science
What are Drugs? - Noadswood Science

... Around 12,000 deformed Thalidomide babies born, 4,000 died in their first year. • Drug was then banned but now being used successfully to treat leprosy in 3rd world ...
< 1 ... 152 153 154 155 156 157 158 159 160 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report